Pubblicazioni

PATENTS

1) 1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury.

Inventors: Pinton, Paolo; Ferrari, Roberto; Giorgi, Carlotta; Trapella, Claudio; Preti, Delia; Morciano, Giampaolo.

Assignee: Maria Cecilia Hospital S.p.A., Italy.

Patent N°: WO 2020021378. A1. Jan 30, 2020.

2) Nuovi inibitori dell’apertura del poro di transizione di permeabilità mitocondriale a struttura spiranica quali potenziali agenti cardioprotettivi.

Inventors: Pinton, Paolo; Ferrari, Roberto; Giorgi, Carlotta; Trapella, Claudio; Preti, Delia; Morciano, Giampaolo.

Assignee: Maria Cecilia Hospital S.p.A., Italy.

Patent N°: P020704IT-01. July 27, 2018.

3) Preparation of fused purine derivatives as adenosine A3 receptor modulators.

Inventors: Baraldi, Pier Giovanni; Borea, Pier Andrea; Preti, Delia; Tabrizi, Mojgan Aghazadeh.

Assignee: King Pharmaceuticals Research and Development, Inc., USA.

Patent N°: US 7435740. B2. Oct 14, 2008.

4) Preparation of adenosine A2B receptor agonists for use as prodrugs treating diseases in mammals.

Inventors: Baraldi, Pier Giovanni; Borea, Pier Andrea; Moorman, Allan R.; Preti, Delia.

Assignee: King Pharmaceuticals Research and Development, Inc., USA.

Patent N°: US 20070281902. A1. Dec 6, 2007.

5) Preparation of fused purine derivatives as adenosine A3 receptor modulators.

Inventors: Baraldi, Pier; Borea, Pier Andrea; Preti, Delia; Tabrizi, Mojgan Aghazadeh.

Assignee: King Pharmaceuticals Research and Development, Inc., USA.

Patent N°: WO 2006083916. A2. Aug 10, 2006.